4//SEC Filing
Shah Jatin 4
Accession 0001209191-22-011650
CIK 0001503802other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 4:19 PM ET
Size
5.2 KB
Accession
0001209191-22-011650
Insider Transaction Report
Form 4
Shah Jatin
EVP, Chief Medical Officer
Transactions
- Sale
Common Stock
2022-02-17$12.12/sh−1,306$15,833→ 129,450 total
Footnotes (2)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
- [F2]The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001782186
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 4:19 PM ET
- Size
- 5.2 KB